Sparassis Radicata (Sparassis radicata): Benefits, Dosage, Safety & Evidence

Questions fréquentes

How does Sparassis radicata work to support the immune system?

Sparassis radicata contains bioactive beta-glucans and polysaccharides that stimulate immune function by activating macrophages, natural killer cells, and T-lymphocytes. These compounds bind to specific immune cell receptors such as Dectin-1, triggering enhanced immune surveillance and cytokine production. The mushroom's immunostimulant properties may also support anti-tumor activity through immune modulation. Evidence Level: C (preliminary studies and traditional use).

Does Sparassis radicata interact with any medications?

Sparassis radicata may interact with immunosuppressant medications due to its immunostimulant properties. Patients taking corticosteroids, cyclosporine, tacrolimus, or other immune-suppressing drugs should avoid this mushroom, as it may reduce medication effectiveness. Patients undergoing chemotherapy or taking biologic agents should consult their oncologist before use, as immune modulation may affect treatment outcomes. Evidence Level: C (theoretical based on mechanism).

What is the recommended dosage for Sparassis radicata extract?

The typical adult dosage for Sparassis radicata extract is 500-2000mg daily, usually divided into one or two doses. Standardized extracts with verified beta-glucan content are preferred for consistent therapeutic results. Dosage may vary based on product concentration and intended use. Consult a qualified healthcare practitioner for personalized dosing recommendations, especially when using for immune support during acute conditions. Evidence Level: C (traditional use and preliminary research).

Is Sparassis radicata safe to take during pregnancy or breastfeeding?

Sparassis radicata is not recommended during pregnancy or breastfeeding. The mushroom's potent immunostimulant beta-glucans could potentially affect fetal development or nursing infants through immune modulation. There is insufficient safety data to support use in these populations. Women who are pregnant, planning pregnancy, or breastfeeding should avoid this supplement and consult their healthcare provider for safe alternatives. Evidence Level: C (precautionary based on mechanism).

Can people with autoimmune conditions take Sparassis radicata mushroom?

Individuals with autoimmune conditions such as lupus, rheumatoid arthritis, multiple sclerosis, or Hashimoto's thyroiditis should avoid Sparassis radicata. The mushroom's immunostimulant beta-glucans may overactivate the immune system, potentially worsening autoimmune symptoms or triggering disease flare-ups. This contraindication applies to all immune-enhancing medicinal mushrooms. Patients should consult a qualified healthcare provider before considering use. Evidence Level: C (theoretical based on mechanism).

Fiche d'information compilée à partir de PubMed

Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.

Compilé à partir de 27 articles PubMed · modèle : gemma4:31b

Résumé

Sparassis radicata is closely related to Sparassis crispa, a genus of edible and medicinal mushrooms known for high beta-glucan content and various pharmacological activities [PMID:33366786, PMID:40583786].

Contexte

Sparassis species, commonly known as cauliflower mushrooms, are edible fungi found in Asia, Europe, and North America [PMID:37755018, PMID:40583786]. Sparassis radicata is phylogenetically closely related to Sparassis crispa [PMID:33366786].

Usages traditionnels

Sparassis crispa is widely used in traditional Chinese medicine due to its bioactive substances [PMID:30375506, PMID:33366786] and has been used historically in traditional Asian medicine [PMID:30395976].

Composés actifs

Key bioactive components include high levels of beta-glucans (up to 43.6% dry weight), polysaccharides, phenolic compounds (such as veratric acid), terpenoids, lectins, and sparassol [PMID:40583786, PMID:35513833, PMID:26914455].

Mécanisme d'action

Mechanisms include immune activation [PMID:40583786], activation of natural killer (NK) cells and promotion of antibody-dependent cell-mediated cytotoxicity (ADCC) [PMID:37017658], suppression of TLR-mediated NF-κB and MAPK signaling pathways [PMID:30395976], and regulation of the AKT/NRF2 and ERK/CREB pathways for neuroprotection [PMID:37755018].

Preuves cliniques

Preuve BFacial Wrinkles

Veratric acid derived from cauliflower mushroom demonstrated clinical effects on facial wrinkle improvement by attenuating MMP expression [PMID:26914455].

Preuve DObesity/Metabolic Syndrome (Animal Models)

S. crispa powder suppressed body weight and visceral fat gain in ovariectomized mice [PMID:38545380]; lacto-fermented S. crispa ameliorated hepatic steatosis in obese zebrafish [PMID:32466711]; and a synbiotic of beta-glucans and L. fermentum lowered visceral fat mass in estrogen-deficient rats [PMID:29151980].

Preuve DCancer (In Vitro)

Crude polysaccharides from S. crispa inhibited the proliferation of human colon cancer cell lines (Caco-2, LS180, and HT-29) [PMID:33419097].

Preuve DNeuroprotection (In Vitro)

Ethanol extract of S. crispa reduced glutamate-induced cell death and ROS generation in mouse hippocampal HT22 cells [PMID:37755018].

Sécurité et effets indésirables

Crude polysaccharides from S. crispa were found to be non-toxic to normal human colon epithelial CCD841 CoN cells [PMID:33419097].

Synthèse des preuves

The evidence consists primarily of in vitro studies and animal models (Level D) and a few reviews (Level C), with one clinical trial (Level B) regarding a specific derivative (veratric acid) for skin health. Most data pertains to S. crispa and S. latifolia rather than S. radicata specifically.

Sources PubMed

1.PMID: 40583786 (2026) — Cauliflower mushroom (Sparassis): a promising functional food with nutritional and medicinal properties. · Critical reviews in food science and nutrition
2.PMID: 35513833 (2022) — Medicinal, nutritional, and nutraceutical potential of Sparassis crispa s. lat.: a review. · IMA fungus
3.PMID: 38545380 (2024) — Wood cauliflower mushroom (Sparassis crispa) suppresses the body weight and visceral fat increased by ovariectomy in mice. · Current research in food science
4.PMID: 23586068 (2013) — Natural products and biological activity of the pharmacologically active cauliflower mushroom Sparassis crispa. · BioMed research international
5.PMID: 33366786 (2020) — The complete mitochondrial genome of an edible mushroom, Sparassis crispa.

Sparassis Radicata

Sources et citations

Calculer une dose sûre de Sparassis Radicata